Investigating the relationship between inflammatory bowel disease and C. diff

Mouse model reveals gut inflammation makes it easier for bacterium to set up shop.

9:39 AM

Author | Madeline Barron

stomach pain woman red circle pulsing ontop of intestines
Justine Ross, Michigan Medicine

The gut-infecting bacterium, Clostridioides difficile, commonly known as C. diff, sickens half a million people and causes up to 30,000 deaths in the United States each year. 

Often, C. difficile infection occurs after antibiotic treatment, which inadvertently kills members of the gut microbiota—the community of microbes living in our intestines—that normally bar C. difficile from invading the gut.

However, people with inflammatory bowel disease, also known as IBD, a set of conditions characterized by inflammation of the digestive tract, are at increased risk for C. difficile, even if they haven't taken antibiotics. This suggests that something about the IBD gut supports C. difficile colonization and growth. Yet, the relationship between IBD and C. diff is not well understood.  

A recent study from researchers at the University of Michigan Medical School sheds light on factors underlying the development of C. diff in the setting of IBD. Using a mouse model, they show that inflammation and changes in the gut microbiota associated with IBD promote C. difficile intestinal colonization, even without antibiotics. 

Down the line, these findings could facilitate the development of strategies to prevent or treat C. diff in IBD patients.  

Developing a model to understand the relationship between C. diff and IBD

It's generally believed that IBD occurs when the immune system mistakes normal intestinal microbes for harmful invaders and attacks them, leading to chronic gut inflammation. The cause of C. diff is similarly complex, with the immune system, microbiota, and C. difficile itself playing a role in infection.

When it comes to such complex diseases, scientists use mouse models to experimentally investigate why, and how, they develop. While there are existing models for IBD and C. diff, prior to this study, a system to examine both conditions simultaneously did not exist. 

For Vincent B. Young, M.D., Ph.D., professor in the Department of Internal Medicine and Infectious Diseases Division at the University of Michigan Medical School and senior author on the study, this technical gap offered a chance to unite phases of a career encompassing work with both C. diff and IBD. 

"I started out by exploring the role of the microbiome in IBD using animal models," said Young. Specifically, his early research centered on a mouse model that mimics the dysregulated immune-microbiota interactions characteristic of human IBD. The system uses mice lacking a protein, called IL-10, that normally suppresses inflammatory responses. Without it, animals are prone to developing intestinal inflammation. Whether they do, however, depends on their microbiota. 

Most bacteria that live in the mouse gut, including a type called Helicobacter hepaticus, normally co-exist peacefully with their host. However, in animals with altered immune systems, like those lacking IL-10, this bacterium can trigger IBD.

While Young notes that H. hepaticus does not cause IBD in people, the model reflects "principles relevant to human IBD," namely the aberrant interplay between normal members of the microbiota and the immune system in susceptible individuals.

Thanks in part to his involvement with the Human Microbiome Project and experience as an infectious disease physician, Young's research focus eventually shifted away from IBD toward mouse models of C. diff, where it has stayed for the past 15 years. 

However, when the study's first author, Lisa Abernathy-Close, Ph.D., a postdoc who was interested in IBD joined the lab, Young thought it would be a perfect time to revisit his earlier work and "see if we could use this model of IBD to understand the intersection between C. diff and IBD." 

MORE FROM THE LAB: Subscribe to our weekly newsletter 

It is well known that C. diff commonly infects people who have had their gut microbiota disturbed by antibiotics, which creates an opening for C. difficile to colonize, proliferate, and damage the intestine. Does IBD do something similar?

"IBD, by the nature of its name, is characterized by gut inflammation. We wanted to figure out if that inflammation in and of itself could predispose animals to C. diff," Young said.

To that end, the researchers colonized IL-10-deficient mice with H. hepaticus to trigger IBD. After two weeks, when the mice had developed significant intestinal inflammation, they were challenged with C. difficile. Said Young, "lo and behold, without antibiotics, animals were colonized by C. difficile," indicating that inflammation alone was enough to promote C. diff

Notably, the composition of the gut microbiota in mice with IBD, and thus susceptible to C. diff, differed from those without IBD and resistant to infection. This suggests that, like antibiotics, inflammation may alter gut microbiota to create a permissive environment for C. difficile. Additionally, animals with IBD and C. diff had worse disease compared to animals with IBD alone, further mirroring clinical outcomes in human patients, where the onset of C. diff can exacerbate IBD symptoms.

Next steps for investigating C. diff and IBD

The results from this study have multiple implications. For one, having a model to study altered immunity and the microbiota as they relate to IBD-associated C. diff is a technical step forward. This could help develop ways to protect IBD patients from infection.

Additionally, Young notes there are multiple risk factors for C. diff in addition to antibiotics and IBD, including advancing age and having other pre-existing conditions. As such, this system provides "a new way for us to look at what leads to C. diff susceptibility in general, not just for those patients with IBD."

Like Podcasts? Add the Michigan Medicine News Break on iTunes, Google Podcasts or anywhere you listen to podcasts.

"Ultimately," he said, "this could help us understand both IBD and C. diff together, but also separately."

With that, the team is using their model to further disentangle interactions between the immune system, microbiota, and C. difficile colonization and infection. In doing so, they hope to provide a more nuanced understanding of features of the gut that promote or prevent C. diff, in IBD and beyond. 

Paper cited: "Intestinal Inflammation and Altered Gut Microbiota Associated with Inflammatory Bowel Disease Render Mice Susceptible to Clostridioides difficile Colonization and Infection," mBio. DOI: 10.1128/mBio.02733-20

More Articles About: Lab Report Inflammatory Bowel Disease (IBD) Hospital Acquired Infections Digestive (GI) Conditions
Health Lab word mark overlaying blue cells
Health Lab

This article is from the Health Lab digital publication.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]


Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Featured News & Stories girl man woman window standing by window
Health Lab
Doctors discover novel way to treat pancreatic complication in child with trisomy 18
Faith Smith spent nearly a year in and out of the hospital for pancreatic problems. Because of her complex medical issues, the standard approach to treatment wasn’t an option
microscope cells glioma
Health Lab
Researchers circumvent radiation resistance in subtype of brain tumors
University of Michigan Rogel Cancer Center researchers find ZMYND8 gene plays a critical role in conferring radiation resistance on brain tumors with IDH1 mutation.
tavr stroke blue cardiovascular red inside blue background
Health Lab
Hospitals without highest stroke care designation may miss them after heart procedure
Using stroke as a measure of quality after TAVR could put stroke centers at a disadvantage, the study suggests
cancer cells microscope blue green
Health Lab
Certain gene signaling rewires tumors after immunotherapy
For some patients, immunotherapy furthers tumor progression instead of halting it. What distinguishes those who benefit from those who don’t?
Brain wiring diagram prosthetic hand
Health Lab
Simple neural networks outperform the state-of-the-art for controlling robotic prosthetics
Simple neural networks outperform the state-of-the-art for controlling robotic prosthetics
Health Lab
Massive international study uncovers genes involved in heart disease
Scientists link dozens of new genome sites to coronary artery disease risk and pioneer a powerful method for illuminating the biological roots of common disease.